As Nike (NKE) Shares Rose, Sustainable Growth Advisers LP Has Trimmed Its Holding by $43.72 Million; Gilead Sciences (GILD) Stake Has Lifted by Steinberg Global Asset Management

August 10, 2018 - By Mark Williams

Gilead Sciences, Inc. (NASDAQ:GILD) Logo

Steinberg Global Asset Management increased its stake in Gilead Sciences Inc (GILD) by 288.06% based on its latest 2018Q1 regulatory filing with the SEC. Steinberg Global Asset Management bought 36,448 shares as the company’s stock declined 17.62% with the market. The institutional investor held 49,101 shares of the health care company at the end of 2018Q1, valued at $3.70M, up from 12,653 at the end of the previous reported quarter. Steinberg Global Asset Management who had been investing in Gilead Sciences Inc for a number of months, seems to be bullish on the $99.20B market cap company. The stock decreased 1.95% or $1.52 during the last trading session, reaching $76.52. About 3.33 million shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has risen 4.37% since August 10, 2017 and is uptrending. It has underperformed by 8.20% the S&P500. Some Historical GILD News: 16/04/2018 – Gilead’s Complera Rises After 1-Wk Fall, Triumeq Advances: HIV; 05/03/2018 – GlaxoSmithKline: ViiV Healthcare Announces Positive New Dolutegravir Data; 10/05/2018 – @JimCramer vets biotech giants Biogen, Celgene, Gilead and Regeneron for positive prospects; 15/05/2018 – Gilead fortifies its cell therapy status, expanding into three new facilities and teaming with NCI $GILD; 23/03/2018 – Gilead TAF Sales Rise 3%, HIV Combo Pills Gain 2%; 20/04/2018 – STAT Plus: NIH is sued for plans to award exclusive license for CAR-T therapy to Gilead; 12/03/2018 – Gilead Sciences Names Andrew Cheng Chief Medical Officer; 07/05/2018 – AbbVie’s Mavyret Falls After 1-Wk Rise, Epclusa Advances: Hep-C; 30/05/2018 – GILEAD, GALAPAGOS: EQUATOR ACHIEVES PRIMARY ENDPOINT OF ACR20; 27/04/2018 – European CHMP Adopts Positive Opinion for Gilead’s Biktarvy(R) (Bictegravir, Emtricitabine, Tenofovir Alafenamide)

Sustainable Growth Advisers Lp decreased its stake in Nike Inc (NKE) by 12.72% based on its latest 2018Q1 regulatory filing with the SEC. Sustainable Growth Advisers Lp sold 662,368 shares as the company’s stock rose 3.73% while stock markets declined. The institutional investor held 4.54M shares of the consumer non-durables company at the end of 2018Q1, valued at $301.91M, down from 5.21 million at the end of the previous reported quarter. Sustainable Growth Advisers Lp who had been investing in Nike Inc for a number of months, seems to be less bullish one the $129.20 billion market cap company. The stock decreased 0.66% or $0.54 during the last trading session, reaching $80.72. About 3.12 million shares traded. NIKE, Inc. (NYSE:NKE) has risen 38.01% since August 10, 2017 and is uptrending. It has outperformed by 25.44% the S&P500. Some Historical NKE News: 20/03/2018 – Nike Vision Introduces 2018 Golf Sunglass Collection; 04/04/2018 – Nike exec says co needs to step up promotion of women, minorities; 22/03/2018 – NIKE INC – QTRLY NORTH AMERICA TOTAL REVENUE $3,571 MLN VS $3,782 MLN REPORTED LAST YEAR; 15/05/2018 – PERSHING SQUARE CAPITAL MANAGEMENT – CHANGE IN HOLDINGS ARE AS OF MARCH 31, 2018 AND COMPARED WITH THE PREVIOUS QUARTER ENDED AS OF DEC 31, 2017; 22/03/2018 – Nike: Cash and Equivalents and Short-Term Investments Were $4.8 Billion at Feb. 28; 04/04/2018 – Nike HR Chief: Half of Staff Are Women, 29% of VPs Are Women — Memo; 06/04/2018 – Nike welcomed Tiger Woods back to the Masters with an ad showing his career highlights; 08/05/2018 – Box Founds Future of Work Council to Bring Together Leaders From Innovative Enterprises Like American Express, NIKE and Farmers lnsurance┬«; 22/03/2018 – JUST IN: Bill Ackman’s Pershing Sq. cashes out of Nike stake after 32% gain, likely making about $100M – Dow Jones; 16/03/2018 – Pro4ma founder and CEO Liz Dunn says the sudden departure of two top Nike executives is indicative of a cultural problem of workplace misconduct

More important recent NIKE, Inc. (NYSE:NKE) news were published by: Bizjournals.com which released: “Ex-employees sue Nike over pay, gender discrimination” on August 10, 2018, also Benzinga.com published article titled: “Morgan Stanley Picks Nike Over Foot Locker, Says Brand’s Growth May Not Translate To Retail Partner”, Seekingalpha.com published: “Nike Stock’s Valuation Stutter” on August 07, 2018. More interesting news about NIKE, Inc. (NYSE:NKE) was released by: Investorideas.com and their article: “#PlaybyPlay: EA Sports (NasdaqGS: $EA) @EASPORTS Madden NFL 19 Launches with a Host of New Features and …” with publication date: August 10, 2018.

Among 44 analysts covering Nike Inc. (NYSE:NKE), 24 have Buy rating, 2 Sell and 18 Hold. Therefore 55% are positive. Nike Inc. had 255 analyst reports since July 29, 2015 according to SRatingsIntel. As per Friday, September 25, the company rating was maintained by Stifel Nicolaus. The firm earned “Hold” rating on Friday, June 30 by FBR Capital. On Monday, September 28 the stock rating was maintained by S&P Research with “Buy”. The stock has “Buy” rating by Citigroup on Wednesday, September 28. The firm earned “Overweight” rating on Thursday, January 19 by Atlantic Securities. On Wednesday, March 23 the stock rating was maintained by Barclays Capital with “Overweight”. The rating was maintained by JP Morgan with “Buy” on Thursday, March 23. On Friday, July 21 the stock rating was maintained by Stifel Nicolaus with “Buy”. The rating was maintained by Instinet on Thursday, March 23 with “Buy”. The firm has “Buy” rating given on Wednesday, September 27 by Stifel Nicolaus.

Since February 27, 2018, it had 0 insider buys, and 12 selling transactions for $54.80 million activity. $223,403 worth of stock was sold by Campion Andrew on Tuesday, July 24. On Tuesday, June 5 SPRUNK ERIC D sold $3.33 million worth of NIKE, Inc. (NYSE:NKE) or 45,000 shares. The insider Matheson Monique S. sold $1.28M. PARKER MARK G had sold 135,000 shares worth $9.86 million. Another trade for 40,000 shares valued at $3.06M was sold by Krane Hilary K.

Investors sentiment decreased to 0.65 in 2018 Q1. Its down 0.09, from 0.74 in 2017Q4. It fall, as 64 investors sold NKE shares while 515 reduced holdings. 100 funds opened positions while 277 raised stakes. 997.42 million shares or 1.70% less from 1.01 billion shares in 2017Q4 were reported. First Quadrant Lp Ca, California-based fund reported 5,900 shares. Moreover, Orbis Invest Mgmt (Us) Ltd Liability Corp has 6.32% invested in NIKE, Inc. (NYSE:NKE). Jarislowsky Fraser Limited, Quebec – Canada-based fund reported 211,113 shares. Federated Invsts Incorporated Pa, a Pennsylvania-based fund reported 21,510 shares. Cypress Management Lc (Wy) stated it has 6,626 shares. Tributary Ltd Liability Co stated it has 8,700 shares or 0.05% of all its holdings. Tradewinds Mgmt Limited Co owns 557 shares. Bristol John W And New York owns 1.30 million shares. 16,980 are owned by Institute For Wealth Mngmt Limited Liability Co. Envestnet Asset has 0.03% invested in NIKE, Inc. (NYSE:NKE). Jlb And Assocs holds 2.03% or 141,710 shares. Commerzbank Aktiengesellschaft Fi reported 0.38% in NIKE, Inc. (NYSE:NKE). Silvercrest Asset Management Gru Limited Liability Company has invested 0.04% in NIKE, Inc. (NYSE:NKE). Caprock Group Inc has 14,320 shares for 0.2% of their portfolio. Campbell Newman Asset Mgmt Inc has invested 0.45% of its portfolio in NIKE, Inc. (NYSE:NKE).

Sustainable Growth Advisers Lp, which manages about $6.01B and $8.42 billion US Long portfolio, upped its stake in Ctrip.Com International Ltd (NASDAQ:CTRP) by 57,463 shares to 1.34M shares, valued at $62.58M in 2018Q1, according to the filing. It also increased its holding in Sanlam Ltd (SLLDY) by 181,067 shares in the quarter, for a total of 192,337 shares, and has risen its stake in Schlumberger Ltd (NYSE:SLB).

Analysts await NIKE, Inc. (NYSE:NKE) to report earnings on September, 25. They expect $0.61 EPS, up 7.02% or $0.04 from last year’s $0.57 per share. NKE’s profit will be $976.33M for 33.08 P/E if the $0.61 EPS becomes a reality. After $0.69 actual EPS reported by NIKE, Inc. for the previous quarter, Wall Street now forecasts -11.59% negative EPS growth.

Since February 9, 2018, it had 0 insider purchases, and 17 selling transactions for $25.62 million activity. WILSON GAYLE E sold $4.68 million worth of Gilead Sciences, Inc. (NASDAQ:GILD) on Friday, February 9. MARTIN JOHN C sold $3.41 million worth of stock or 50,000 shares. Shares for $1.97M were sold by Alton Gregg H on Thursday, March 1. Washington Robin L sold $401,566 worth of stock or 5,000 shares.

More notable recent Gilead Sciences, Inc. (NASDAQ:GILD) news were published by: Seekingalpha.com which released: “Gilead: Is The Drama Over?” on August 01, 2018, also Nasdaq.com with their article: “Gilead Sciences (GILD) Q2 Earnings and Revenues Surpass Estimates” published on July 25, 2018, 247Wallst.com published: “Why Have Short Sellers Backed Off Major Biotechs?” on August 10, 2018. More interesting news about Gilead Sciences, Inc. (NASDAQ:GILD) were released by: Seekingalpha.com and their article: “Gilead Sciences Is A Solid Buy In 2018” published on August 05, 2018 as well as Seekingalpha.com‘s news article titled: “Gilead: A Bell Tolls, And A Window Of Opportunity Opens” with publication date: August 06, 2018.

Investors sentiment increased to 0.88 in 2018 Q1. Its up 0.08, from 0.8 in 2017Q4. It improved, as 71 investors sold GILD shares while 519 reduced holdings. 114 funds opened positions while 404 raised stakes. 976.44 million shares or 0.39% more from 972.68 million shares in 2017Q4 were reported. Grandfield And Dodd Ltd Limited Liability Company holds 138,935 shares or 1.17% of its portfolio. Lazard Asset Management Ltd Liability holds 0.14% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD) for 977,475 shares. Blackrock holds 0.38% in Gilead Sciences, Inc. (NASDAQ:GILD) or 105.24M shares. Strategic Limited Liability Company stated it has 1.03% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Montecito Savings Bank Tru owns 9,885 shares. Amica Mutual reported 0.51% stake. Lakeview Cap Ptnrs Limited Liability holds 4,451 shares or 0.26% of its portfolio. Bradley Foster & Sargent Ct holds 57,238 shares or 0.16% of its portfolio. Amer Ins Tx reported 0.4% in Gilead Sciences, Inc. (NASDAQ:GILD). 203,600 were accumulated by Underhill Mngmt Ltd Liability Com. Macguire Cheswick Tuttle Investment Counsel Lc accumulated 23,626 shares. Moreover, Arga Limited Partnership has 0.45% invested in Gilead Sciences, Inc. (NASDAQ:GILD) for 52,904 shares. Calamos Advsrs Limited Liability Corporation holds 321,033 shares or 0.16% of its portfolio. Symphony Asset Mngmt Ltd Liability reported 0.25% stake. Bb&T Corp reported 227,827 shares or 0.33% of all its holdings.

Steinberg Global Asset Management, which manages about $604.10M and $678.24 million US Long portfolio, decreased its stake in Walgreens Boots Alliance Inc by 15,000 shares to 3,421 shares, valued at $224,000 in 2018Q1, according to the filing. It also reduced its holding in Altria Group Inc (NYSE:MO) by 6,298 shares in the quarter, leaving it with 98,457 shares, and cut its stake in Chevron Corp New (NYSE:CVX).

Gilead Sciences, Inc. (NASDAQ:GILD) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts